TSXV - Delayed Quote
CAD
NurExone Biologic Inc. (NRX.V)
0.5000
+0.0250
(+5.26%)
At close: November 6 at 3:49:26 PM EST
Loading chart for NRX.V
- Previous Close
0.4750 - Open
0.5000 - Bid 0.4800 x --
- Ask 0.5400 x --
- Day's Range
0.4900 - 0.5000 - 52 Week Range
0.4350 - 0.7600 - Volume
10,525 - Avg. Volume
22,612 - Market Cap (intraday)
46.023M - Beta (5Y Monthly) 0.34
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1100 - Earnings Date (est.) Nov 25, 2026
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
-- - Moby Rating Neutral
Recent News
View MorePerformance Overview
Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
NRX.V
26.47%
S&P/TSX Composite index (^GSPTSE)
12.31%
1-Year Return
NRX.V
29.58%
S&P/TSX Composite index (^GSPTSE)
18.89%
3-Year Return
NRX.V
66.67%
S&P/TSX Composite index (^GSPTSE)
80.53%
5-Year Return
NRX.V
16.28%
S&P/TSX Composite index (^GSPTSE)
66.80%
Earnings Trends
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-142.12%
-
Return on Equity (ttm)
-450.96%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-6.31M
-
Diluted EPS (ttm)
-0.1100
Balance Sheet and Cash Flow
-
Total Cash (mrq)
1.01M
-
Total Debt/Equity (mrq)
4.11%
-
Levered Free Cash Flow (ttm)
-1.6M
